Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors

This publication has 52 references indexed in Scilit:

• Neuroblastoma
  Seminars in Pediatric Surgery, 2012
• Polo-Like Kinase 1 is a Therapeutic Target in High-Risk Neuroblastoma
  Clinical Cancer Research, 2011
• Myc proteins as therapeutic targets
  Oncogene, 2010
• Use of single-pill combination therapy in the evolving paradigm of hypertension management
  Expert Opinion on Pharmacotherapy, 2009
• Genomic and clinical analyses of 2p24 and 12q13‐q14 amplification in alveolar rhabdomyosarcoma: A report from the Children's Oncology Group
  Genes, Chromosomes and Cancer, 2009
• Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
  Genome Biology, 2008
• Brd4 Recruits P-TEFb to Chromosomes at Late Mitosis To Promote G₁ Gene Expression and Cell Cycle Progression
  Molecular and Cellular Biology, 2008
• Moderated statistical tests for assessing differences in tag abundance
  Bioinformatics, 2007
• MYCN in neuronal tumours
  Cancer Letters, 2004
• Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping
  Journal of Neurosurgery, 2000